TransMedics Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89377M1099
USD
124.70
1.22 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
160.76
143.82
157.37
143.54
121.62
108.76
114.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
160.76
143.82
157.37
143.54
121.62
108.76
114.31
Raw Material Cost
67.35
59.35
60.88
55.41
49.61
48.02
45.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.35
3.49
3.48
3.46
3.57
3.62
3.62
Selling and Distribution Expenses
51.44
45.91
43.99
43.52
46.91
42.56
42.80
Other Expenses
1.73
1.18
1.25
1.37
1.29
1.06
1.02
Total Expenditure (Excl Depreciation)
139.49
120.52
120.80
116.09
112.98
104.84
101.80
Operating Profit (PBDIT) excl Other Income
21.299999999999997
23.3
36.6
27.400000000000002
8.6
3.9000000000000004
12.5
Other Income
3.71
3.22
3.09
2.69
1.92
3.94
3.27
Operating Profit (PBDIT)
32.45
33.37
46.39
36.27
16.24
13.04
20.38
Interest
3.35
3.49
3.48
3.46
3.57
3.62
3.62
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
93.41
84.47
96.49
88.13
72.01
60.74
69.16
Depreciation
7.47
6.85
6.73
6.14
5.68
5.18
4.60
Profit Before Tax
21.63
23.03
36.18
26.68
6.99
4.25
12.15
Tax
-83.75
-1.29
1.27
0.99
0.13
0.03
-0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.38
24.32
34.91
25.68
6.86
4.22
12.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.38
24.32
34.91
25.68
6.86
4.22
12.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
105.38
24.32
34.91
25.68
6.86
4.22
12.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
473.10
355.20
318.10
266.31
228.60
209.92
189.89
Earnings per share (EPS)
2.58
0.66
0.92
0.7
0.19
0.12
0.35
Diluted Earnings per share
2.58
0.66
0.92
0.7
0.19
0.12
0.35
Operating Profit Margin (Excl OI)
13.23%
16.2%
23.24%
19.12%
7.11%
3.61%
10.94%
Gross Profit Margin
18.1%
20.78%
27.27%
22.86%
10.42%
8.66%
14.66%
PAT Margin
65.55%
16.91%
22.18%
17.89%
5.64%
3.88%
10.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 32.24% vs 49.75% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 1,427.54% vs 72.50% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 100.70% vs 126.98% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -5.56% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of TransMedics Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
160.76
57.80
102.96
178.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
160.76
57.80
102.96
178.13%
Raw Material Cost
67.35
15.39
51.96
337.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.35
0.00
3.35
Selling and Distribution Expenses
51.44
44.25
7.19
16.25%
Other Expenses
1.73
0.90
0.83
92.22%
Total Expenditure (Excl Depreciation)
139.49
68.69
70.80
103.07%
Operating Profit (PBDIT) excl Other Income
21.27
-10.88
32.15
295.50%
Other Income
3.71
2.13
1.58
74.18%
Operating Profit (PBDIT)
32.45
-6.64
39.09
588.70%
Interest
3.35
0.00
3.35
Exceptional Items
0.00
-11.90
11.90
100.00%
Gross Profit (PBDT)
93.41
42.41
51.00
120.25%
Depreciation
7.47
2.11
5.36
254.03%
Profit Before Tax
21.63
-20.65
42.28
204.75%
Tax
-83.75
-2.34
-81.41
-3,479.06%
Provisions and contingencies
0
0
0.00
Profit After Tax
105.38
-18.31
123.69
675.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.38
-18.31
123.69
675.53%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
105.38
-18.31
123.69
675.53%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
473.10
344.18
128.92
37.46%
Earnings per share (EPS)
2.58
-0.37
2.95
797.30%
Diluted Earnings per share
2.58
-0.37
2.95
797.30%
Operating Profit Margin (Excl OI)
13.23%
-18.83%
0.00
32.06%
Gross Profit Margin
18.10%
-32.08%
0.00
50.18%
PAT Margin
65.55%
-31.68%
0.00
97.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16.08 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 11.82% vs -8.64% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 32.24% vs 49.75% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.54 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 333.74% vs -30.37% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 1,427.54% vs 72.50% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.87 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -4.65% vs -30.48% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 100.70% vs 126.98% in Dec 2024

Quarterly - Interest
Interest 0.34 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.86% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -5.56% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.23%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024